The Latest Advances in Dementia and Alzheimer’s Treatments and Research, Sept. 23rd

Presented by Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association

Translate to Spanish or other 102 languages!

The Information will be presented by Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association. Image Source: www.alz.org/
The Information will be presented by Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association. Image Source: www.alz.org/
- Advertisement -

EDINBURG, Texas – The Alzheimer’s Association San Antonio and South Texas Chapter proudly invites Rio Grande Valley residents to the Alzheimer’s & Dementia Research Update: The Latest in Alzheimer’s Disease Treatments and Research on September 23, 2025. The event will feature Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association. Dr. Carrillo oversees the Association’s research initiatives, guiding efforts to accelerate progress in the prevention and treatment of Alzheimer’s and all other dementia. 

“We are proud to be partnering with DHR Health Institute for Research and Development and Methodist Healthcare Ministries to bring this event to the Rio Grande Valley,” says Marcie McDonald, Executive Director, Alzheimer’s Association San Antonio & South Texas Chapter. “Access to the latest information and resources is critical. We are incredibly fortunate to bring together such a distinguished group of local experts.”

This event, which is free and open all, will be held from 5:30 p.m. to 7:30 p.m. at the Edinburg Conference Center at the Renaissance. 

- Advertisement -

Following Dr. Carrillo’s Alzheimer’s & Dementia Research Update, there will be a Q&A session with Dr. Carrillo and DHR Health panelists including Dr. Scott Lillibridge, VP & CEO, DHR Health Research & Development Institute, Dr. Jose E. Igoa, Medical Director, DHR Health Behavioral Hospital and Dr. Roberto A. Cruz, Neurologist, DHR Health Neurology Institute and Dr. Monica M. Betancourt-Garcia, VP DHR Health Institute for Research & Development.

Caregivers, students, healthcare professionals, and community members interested in learning more about Alzheimer’s disease and the future of dementia care are invited to attend.

Continuing Education (CE) certificates will be available for Registered Nurses (RN), Certified Nursing Assistants (CNA), Social Workers (SW), Community Health Workers (CHW), and Long-Registration is required to receive CE certificates. 

Don’t miss this opportunity to hear directly from one of the nation’s leading voices in Alzheimer’s research as well as a distinguished group of local experts.

- Advertisement -

There is no charge for the Alzheimer’s & Dementia Research Update, but registration is highly recommended. Register today at bit.ly/ALZRUDHR. For more information or to register by phone, call our 24/7 Helpline at 800.272.3900.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -